{"id":"https://openalex.org/W1814899330","doi":"https://doi.org/10.1111/j.1751-2824.2011.01517.x","title":"Plasma fractionation in Asia\u2013Pacific: challenges and perspectives","display_name":"Plasma fractionation in Asia\u2013Pacific: challenges and perspectives","publication_year":2011,"publication_date":"2011-10-20","ids":{"openalex":"https://openalex.org/W1814899330","doi":"https://doi.org/10.1111/j.1751-2824.2011.01517.x","mag":"1814899330"},"language":"en","primary_location":{"id":"doi:10.1111/j.1751-2824.2011.01517.x","doi":"https://doi.org/10.1111/j.1751-2824.2011.01517.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1751-2824.2011.01517.x","pdf_url":null,"source":{"id":"https://openalex.org/S92625435","display_name":"ISBT Science Series","issn_l":"1751-2816","issn":["1751-2816","1751-2824"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ISBT Science Series","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006405586","display_name":"Thierry Pierre Robert Burnouf","orcid":"https://orcid.org/0000-0002-0507-9243","observed_orcids":["https://orcid.org/0000-0002-0507-9243"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"T. Burnouf","raw_affiliation_strings":["Human Protein Process Sciences (HPPS), Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Human Protein Process Sciences (HPPS), Lille, France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5006405586"],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":1.9179,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.87764156,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"6","issue":"2","first_page":"366","last_page":"372"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12735","display_name":"Blood donation and transfusion practices","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1405","display_name":"Management of Technology and Innovation"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12735","display_name":"Blood donation and transfusion practices","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1405","display_name":"Management of Technology and Innovation"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11116","display_name":"Trauma, Hemostasis, Coagulopathy, Resuscitation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/plasma-fractionation","display_name":"plasma fractionation","score":0.996999979019165},{"id":"https://openalex.org/keywords/plasma-derived-products","display_name":"plasma-derived products","score":0.7490000128746033},{"id":"https://openalex.org/keywords/coagulation-factors","display_name":"coagulation factors","score":0.8080000281333923},{"id":"https://openalex.org/keywords/immunoglobulins","display_name":"immunoglobulins","score":0.9819999933242798},{"id":"https://openalex.org/keywords/albumin","display_name":"albumin","score":0.8640000224113464},{"id":"https://openalex.org/keywords/blood-transfusion-services","display_name":"blood transfusion services","score":0.8220000267028809},{"id":"https://openalex.org/keywords/plasma-apheresis","display_name":"plasma apheresis","score":0.5870000123977661},{"id":"https://openalex.org/keywords/asia-pacific-region","display_name":"Asia-Pacific region","score":0.4449999928474426},{"id":"https://openalex.org/keywords/china","display_name":"China","score":0.6759999990463257}],"concepts":[{"id":"https://openalex.org/C2778258694","wikidata":"https://www.wikidata.org/wiki/Q1923157","display_name":"Cryoprecipitate","level":3,"score":0.56816565990448},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.5164061188697815},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4900435209274292},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44704771041870117},{"id":"https://openalex.org/C2780014101","wikidata":"https://www.wikidata.org/wiki/Q183605","display_name":"Blood transfusion","level":2,"score":0.42622923851013184},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.36670470237731934},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.27612388134002686},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.1699047088623047},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16312336921691895},{"id":"https://openalex.org/C2779036427","wikidata":"https://www.wikidata.org/wiki/Q381899","display_name":"Fibrinogen","level":2,"score":0.15636739134788513}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1111/j.1751-2824.2011.01517.x","doi":"https://doi.org/10.1111/j.1751-2824.2011.01517.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1751-2824.2011.01517.x","pdf_url":null,"source":{"id":"https://openalex.org/S92625435","display_name":"ISBT Science Series","issn_l":"1751-2816","issn":["1751-2816","1751-2824"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ISBT Science Series","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"},{"score":0.5217000246047974,"display_name":"Partnerships for the goals","id":"https://metadata.un.org/sdg/17"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1898668025","https://openalex.org/W1970652156","https://openalex.org/W1974934355","https://openalex.org/W1993947478","https://openalex.org/W2015533801","https://openalex.org/W2024630021","https://openalex.org/W2048966798","https://openalex.org/W2068533441","https://openalex.org/W2079265747","https://openalex.org/W2083017360","https://openalex.org/W2085027388","https://openalex.org/W2101387721","https://openalex.org/W2142726037","https://openalex.org/W2170001106"],"related_works":["https://openalex.org/W1996822171","https://openalex.org/W2787944122","https://openalex.org/W4396728243","https://openalex.org/W2272328724","https://openalex.org/W2997058673","https://openalex.org/W2094097263","https://openalex.org/W4404706377","https://openalex.org/W4387893089","https://openalex.org/W2185125709","https://openalex.org/W65994323"],"abstract_inverted_index":{"Patients":[0],"in":[1,18,41,67,140,255,433,443,493],"every":[2],"country":[3],"should":[4,345,383,397,428,453],"have":[5,70,277,286],"access":[6,72],"to":[7,73,115,130,146,174,187,299,348,355,366,400,475,479],"quality":[8,333,445,494],"blood":[9,35,205,216,228,234,242,246,281,284,294],"products.":[10,29,337,496],"National":[11],"health":[12],"authorities":[13,331],"play":[14],"a":[15,74,103,172,203,213,219,232,238,268,371,379,423],"critical":[16],"role":[17],"ensuring":[19],"that":[20,403],"patients\u2019":[21],"needs":[22,351,409,469],"are":[23,37,194,265,309,473],"met":[24],"with":[25,305],"safe":[26,233],"and":[27,45,123,128,218,225,237,258,262,289,313,326,342,352,386,394,413,441,446,463,488],"cost\u2010effective":[28],"Fractionated":[30],"plasma":[31,78,96,105,111,120,138,176,199,302,336,339,350,359,369,471,482,495],"products,":[32,36],"as":[33,197,370,431],"other":[34],"essential":[38],"therapeutics":[39],"used":[40],"the":[42,68,141,148,159,167,279,290,293,353,434,444,457,461,464,468],"prevention,":[43],"management,":[44],"treatment":[46,132],"of":[47,77,119,124,133,137,158,166,182,292,335,358,378,425,439,448,460,491],"life\u2010threatening":[48],"conditions":[49],"resulting":[50,254],"from":[51,362],"trauma,":[52],"metabolic":[53],"congenital":[54],"deficiencies,":[55],"immunological":[56],"disorders":[57],"or":[58,90,180,315],"infections.":[59],"A":[60,415],"few":[61,269],"high":[62],"development":[63,459],"index":[64],"(HDI)":[65],"countries":[66,109,211,270],"region":[69,142,462],"sufficient":[71],"broad":[75],"portfolio":[76,396],"products":[79,405,452,472],"(coagulation":[80],"factors,":[81],"immunoglobulin,":[82],"albumin)":[83],"through":[84,485],"domestic":[85,183,318,408,449,481],"(e.g.":[86,92,271,410,483],"Australia,":[87],"Japan,":[88],"Korea)":[89],"contract":[91,177,301,380,387,486],"Singapore,":[93,275],"New":[94],"Zealand)":[95],"fractionation":[97,106,178,200,303,321,381,392],"programmes.":[98],"China":[99],"is":[100,143,171,249],"gradually":[101],"establishing":[102],"modern":[104],"industry.":[107],"Other":[108],"face":[110],"product":[112,340,395],"shortages":[113],"leading":[114],"inappropriate":[116,131],"clinical":[117],"use":[118,188],"for":[121,164,374,420,422,470],"transfusion":[122,243,295],"non\u2010virally":[125],"inactivated":[126],"cryoprecipitate,":[127],"ultimately":[129],"patients.":[134],"The":[135,150,391],"volume":[136,151,161],"fractionated":[139,162],"too":[144],"low":[145],"meet":[147,407],"needs.":[149],"(about":[152],"6":[153],"million":[154],"l)":[155],"represents":[156],"20%":[157],"total":[160],"worldwide":[163],"60%":[165],"world":[168],"population.":[169],"There":[170],"rationale":[173],"encourage":[175],"programmes":[179,201,322],"operation":[181],"facilities":[184],"(when":[185],"justified)":[186],"local":[189],"resources.":[190],"However,":[191],"many":[192],"challenges":[193],"being":[195],"faced":[196],"national":[198,215,223,280,283,329],"require":[202,323],"mature":[204,214],"collection":[206,247,357],"infrastructure.":[207],"Unfortunately,":[208],"several":[209],"LDI":[210],"lack":[212,231],"programme":[217,304],"legislative":[220],"framework":[221],"on":[222,227,332],"policies":[224,285],"legislation":[226],"donations.":[229],"They":[230],"donor":[235],"base":[236],"well\u2010organized,":[239],"nationally":[240],"coordinated":[241],"services;":[244],"their":[245],"system":[248],"scattered":[250],"among":[251],"different":[252],"entities,":[253],"non\u2010uniform":[256],"screening":[257],"testing":[259],"procedures.":[260],"Financial":[261],"human":[263],"resources":[264],"lacking.":[266],"Still,":[267],"Hong":[272],"Kong,":[273],"Malaysia,":[274],"Taiwan)":[276],"strengthened":[278],"programmes,":[282],"been":[287],"implemented":[288],"management":[291],"service":[296],"improved,":[297],"allowing":[298],"implement":[300,356],"established":[306],"fractionators.":[307],"Others":[308],"considering":[310],"initiating":[311],"(Indonesia":[312],"Malaysia)":[314],"enhancing":[316],"(Thailand)":[317],"fractionation.":[319,375],"Plasma":[320],"good":[324],"awareness":[325],"understanding":[327],"by":[328,360],"regulatory":[330],"criteria":[334],"Local":[338],"market":[341],"potential":[343],"trends":[344],"be":[346,384,398,429,454],"evaluated":[347,399],"determine":[349],"capacity":[354],"apheresis":[361],"volunteer":[363],"dedicated":[364],"donors":[365],"supplement":[367],"recovered":[368],"source":[372],"material":[373],"Appropriate":[376],"choice":[377],"partner":[382],"made":[385],"terms":[388],"discussed":[389],"carefully.":[390],"technology":[393],"make":[401],"sure":[402],"intended":[404],"can":[406],"range,":[411],"potency":[412],"formulation).":[414],"reimbursement":[416],"policy":[417],"(in":[418],"particular":[419],"IVIG)":[421],"range":[424],"proven":[426],"indications":[427],"established,":[430],"approved":[432],"marketing":[435],"authorization":[436],"dossier.":[437],"Confidence":[438],"clinicians":[440],"patients":[442],"safety":[447],"vs.":[450],"imported":[451],"built.":[455],"With":[456],"economical":[458],"ageing":[465],"population":[466],"trends,":[467],"expected":[474],"increase,":[476],"justifying":[477],"efforts":[478],"fractionate":[480],"initially":[484],"fractionation)":[487],"increase":[489],"guarantee":[490],"supply":[492]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}